Valuations

2017

Jan 2017 ASX listed biotech Valuation of performance rights

Feb 2017 ASX listed 3D printing Valuation of performance rights

Feb 2017 ASX listed prawn farming venture Valuation of project for purposes of native title compensation

Mar 2017 ASX listed water treatment

solutions provider

Independent valuation for acquisition

Mar 2017 ASX listed financing company

Valuation of earn out shares

Mar 2017 Private ophthalmology business Valuation of business for sale

Apr 2017 ASX listed industrial company Independent valuation of the rights to commercialise certain Intellectual Property

April 2017 Offshore supermarket chain Valuation for acquisition

May 2017 Private business providing services

to the not for profit sector

Independent valuation for restructuring

May 2017 Waste disposal project Valuation for purposes of native title compensation

May 2017 ASX listed exploration company Valuation for options and performance rights

May 2017 ASX listed police check and

security verification company

Impairment and options valuation

May 2017 ASX listed cosmetics company Valuation of performance rights

May 2017 ASX listed forestry project IER

May 2017 ASX listed biotech Impairment testing

June 2017 Private, matrimonial Expert valuation, ASX listed holdings

June 2017 Car parking manager Expert valuation for litigation purposes

June 2017 Privately owned

telecommunications company

Valuation for the purposes of a group restructure and sale

June 2017 ASX listed biotech Valuation for impairment testing

June 2017 Iron ore project Valuation for native title compensation

July 2017 ASX listed security and risk

management company

Valuation of options

July 2017 Timber Creek Expert valuation for native title compensation

Aug 2017 Private individual Expert financial report for purposes of family court litigation – valuation of significant

holdings in ASX listed companies

Aug 2017 Private ophthalmology company Valuation for sale

Sept 2017 Private fashion chain Valuation for acquisition

Sept 2016 Private gold exploration company Valuation of options for the purposes of year end accounts and prospective IPO

Sept 2017 ASX listed metals and mining

company

Valuation of options

Sept 2017 ASX listed biotech Valuation of options

Oct 2017 ASX listed oil and gas company Valuation of performance rights

Oct 2017 ASX listed explorer Valuation of options

Oct 2017 ASX listed paper and packaging

company

Valuation of performance rights

Oct 2017 ASX listed mining company Valuation of performance rights

Nov 2017 Brand IP, private milk business Valuation for purposes of restructure and sale

Nov 2017 ASX listed oil and gas company Valuation of options

2016

Jan 2016 ASX listed biotech Valuation of options for executive director

Feb 2016 ASX listed financial services

company

Valuation of business

Feb 2016 ASX listed technology company Valuation of director options

Mar 2016 Private technology company

Independent valuation

Mar 2016 ASX listed oil and gas company

Valuation of options for executive director

Apr 2016 ASX listed exploration and

development company

Valuation of options for directors following a takeover

Apr 2016 ASX listed industrial company Valuation of divisions for purposes of evaluating bids

Apr 2016 ASX listed exploration company Independent valuation for the purposes of s611 item 7

Apr 2016 Oceania Capital Partners Limited Independent valuation for the purposes of s611 item 7, following the share buyback

transaction announced by its parent HCI

Apr 2016 Private arborist company Valuation for the purposes of admitting a new shareholder

May 2016 ASX listed personal care company Valuations for the purposes of AASB 3

May 2016 Private recruitment firm in the

health care space

Valuation for the purposes of an acquisition

May 2016 ASX listed technology rentals

company

Valuation for the purposes of AASB 3

May 2016 ASX listed auto classified business Valuation of performance rights

June 2016 ASX mining services company Valuation of performance rights

June 2016 Privately owned marketing

company

Valuation for the purposes of a group restructure

June 2016 Southern Gold Limited Valuation for the purposes of Listing Rule 7.1A.3

July 2016` Law firm Valuation for the purposes of acquiring a partner’s interests

July 2016 Private 3PL logistics company Valuation for the purposes of acquiring a shareholder’s interests

Aug 2016 Private individual Expert financial report for purposes of family court litigation – valuation of significant

holdings in ASX listed companies

Aug 2016 Private company Expert financial report for purposes of commercial litigation – valuation of brand

Sept 2016 Private gold exploration company Valuation of options for the purposes of year end accounts and prospective IPO

Sept 2016 ASX listed biotech Valuation pursuant to s611 item 7, for change of control transaction

Sept 2016 ASX listed biotech Valuation of options for Executive Chairman; reward benchmarking

Oct 2016 ASX listed resources company Valuation of options for directors and senior management

Oct 2016 ASX listed medical devices

company

Independent Expert Report, for purposes of a Section 611 item 7 transaction

Oct 2016 ASX listed pharmaceutical company Valuation of options for Chief Executive

Nov 2016 Private packaging business Valuation for purposes of capital raising

Nov 2016 ASX listed resources company Valuation of options and performance rights

Nov 2016 ASX listed identity verification

company

Valuation of options and performance rights

2015

Jan 2015 ASX listed oil and gas explorer Valuation of options for executive director

Feb 2015 ASX listed mining exploration

company

Valuation of performance rights for executive director

Feb 2015 Private medical clinic Independent valuation

Feb 2015 ASX listed biotech Valuation of options for executive director

Feb 2015 Law firm Independent valuation for partner dispute

Mar 2015 ASX listed mining company Valuation of options for senior executives

Apr 2015 Private hotel developer Financial model

Apr 2015 Privately owned community assets

owner and operator

Financial model

Apr 2015 Australian Natural Proteins Limited Independent valuation for the purposes of seeking shareholder support to an

acquisition

May 2015 ASX listed mining company Valuation of options for director

May 2015 Privately owned construction

company

Valuation of shares for the purposes of a share sale transaction

May 2015 ASX listed mining company Valuation of options for key executive

June 2015 Jacana Minerals Limited Independent valuation for the purposes of an Independent Expert Report on the

proposed merger with Strandline Resources Limited

June 2015 ASX listed environmental

engineering and services company

Valuation of options for senior executives

June 2015 Private hotel development and

operating trust

Financial model

July 2015 ASX listed payments company Valuation of executive options and performance rights

July 2015 ASX listed gold explorer and

producer

Valuation of executive performance rights

July 2015 ASX listed gold explorer, developer

and producer

Valuation of executive options and performance rights

July 2015 ASX listed biopharmaceutical

company

Valuation of executive options

Aug 2015 Victorian Government business

asset

Valuation for strategic planning purposes

Aug 2015 Private water treatment company

preparing for back door listing

Valuation of executive options

Aug 2015 ASX listed online classified

business

Valuation of executive performance rights

Aug 2015 Public unlisted trading exchange

preparing for back door listing

Report on valuation methodology for restricted employee share issue

Sept 2015 ASX listed biotech

Valuation of performance rights

Sept 2015 Private company with an online

booking system

Valuation of share issue

Sept 2015 ASX listed environmental

engineering and services company

Valuation of options and performance rights to be issued to directors and senior

executives

Oct 2015 ASX listed medical device company

Valuation of IP

Oct 2015 ASX listed payments technology

company

Valuation of performance rights and options

Dec 2015 ASX listed software development

company

Valuation of options for executive and non-executive directors

2014

Jan 2014 Privately owned medical device

company

Valuation for purposes of a capital raising

Mar 2014 Privately owned fund manager

Valuation for purposes of share sales

Mar 2014 Casino gaming business

Valuation and financial modelling for proposed capital raising

May 2014 ASX listed environmental services

company

Valuation of executive options

May 2014 ASX listed satellite company

Valuation of performance rights for senior executive

Jun 2014 Mid cap ASX listed resources

company

Valuation of assets for the purposes of the directors expressing a view on a

proposed corporate transaction

Jun 2014 Unlisted public biotech company

Valuation of director and executive options for accounting purposes

Jul 2014 Mid cap ASX listed resources

company

Valuation of director options

Aug 2014 ASX listed biotech

Valuation of shares for purposes of takeover response strategy

Aug 2014 Private Registered Training

Organisation

Valuation of shares for purposes of sale

Aug 2014 Private Education Provider

Valuation of business for purposes of sale

Sept 2014 ASX listed technology company Independent valuation report for the board, for the purposes of a significant

restructure to be put to shareholders

Sept 2014 ASX listed biotech

Valuation of IP for purposes of impairment testing

Oct 2014 ASX listed biotech

Valuation of performance rights for Directors, for shareholder approval

Oct 2014 ASX listed oil and gas company

Valuation of performance rights for directors, for shareholder approval

2013

Feb 2013 Early stage medical device

company

Valuation for the purposes of a share incentive award

Apr 2013 Immune System Therapeutics Ltd Valuation of director share options

Apr 2013 Australian Natural Proteins Limited Independent Expert Report for section 611 item 7 transaction

Apr 2013 Argo Exploration Limited Valuation of performance rights to be granted to the Directors subject to

shareholder approval

May 2013 Immune System Therapeutics

Limited

Independent Expert Report for section 611 item 7 transaction

Aug 2013 ASX listed biotech

Valuation of subsidiary company shares for related party transaction

Sep 2013 Cellmid Limited

Valuation of Advangen Inc. for purposes of ASX Listing Rule 7.1A.3

Sep 2013 Newsat Limited Valuation of directors\' performance rights and options for purposes of a

shareholder meeting

Oct 2013 HuaYi Resources Limited

Valuation of director and broker options for a new IPO on ASX

Dec 2013 Invigor Group Limited

Independent Expert Report for section 611 item 7 transactions

Dec 2013 ASX listed environmental services

company

Valuation of CEO options for accounting purposes

Dec 2013 Asset management software

company

Valuation of shares for purposes of a share incentive award

2012

Dec 2012 Private pre revenue technology

company

Valuation for purposes of strategic investment

Aug 2012 ASX listed healthcare company

Valuation of consideration options

Aug 2012 ASX listed base metals and gold

exploration and development

company

Valuation of director options for purposes of seeking shareholder approval

Jul 2012 ASX listed graphite explorer and

developer

Valuation of remuneration options for financial reporting purposes

Jul 2012 Private consumer network business Valuation for purposes of issuing executive options

Jul 2012 ASX listed oil and gas exploration

and production company

Valuation of director options for financial reporting purposes

Jul 2012 Public unlisted algae based

industrial waste remediation

company

Fnancial modelling of project activities

Jul 2012 ASX listed environmental products

and services company

Valuation of remuneration options for financial reporting purposes

Jul 2012 ASX listed communications

company

Valuation of executive performance rights

Jun 2012 ASX listed healthcare company

Valuation of healthcare technologies for the purposes of impairment testing

May 2012 Public unlisted biotechnology

company

Valuation of director and executive options for financial reporting purposes

May 2012 ASX listed resources company

Independent Expert Report for strategic alliance transaction

May 2012 High growth private logistics

company

3-way forecast financial model for funding purposes

May 2012 Private greeting card business

Valuation for sale process

May 2012 Private engineering consultancy

business

Valuation for matrimonial settlement

Mar 2012 Private retail group with diverse

interests

3-way forecast financial model for finance application

Mar 2012 ASX listed Anittel Limited

Independent Expert Report for section 611(7) transaction

Mar 2012 ASX listed healthcare company

Valuation of early stage technologies for the purposes of impairment testing

Mar 2012 NSX listed exploration company

Valuation of director and executive options for financial reporting purposes

Feb 2012 ASX listed oil and gas exploration

company

Valuation of director and executive options for financial reporting purposes

Feb 2012 Start up online technology company Financial modelling for scenario analysis

Feb 2012 Private engineering consultancy

Independent valuation for purposes of possible sale transaction

Jan 2012 ASX listed exploration company

Valuation of director and executive options for financial reporting purposes

Jan 2012 ASX listed oil and gas exploration

company

Valuation of director and executive options and consideration options for financial

reporting purposes

Jan 2012 Privately owned precious metal

trading company

Independent valuation for purposes of possible sale transaction

Jan 2012 National supermarket chain

Independent review of financial model for strategic review purposes

2011

Dec 2011 ASX listed mining company

Valuation of director and executive options for financial reporting purposes

Dec 2011 Regional grocery clearance chain Independent valuation

Nov 2011 Manufacturer and distributer of

carbon products

Independent valuation for shareholder exit

Oct 2011 ASX listed Viento Group Limited

Independent Expert Report for section 611 (7) transaction

Oct 2011 Private algae company

Financial modelling updates

Jul - Sept 2011 ASX listed CMA Limited

Financial modelling for purposes of significant recapitalisation